Curanex Pharmaceuticals Inc (CURX)Healthcare | Biotechnology | Jericho, United States | NasdaqCM
4.56 USD
-0.12
(-2.564%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 4.62 +0.06 (1.316%) ⇧ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 2:58 a.m. EDT
The immediate outlook is severely compromised by extreme volatility and a complete lack of fundamental support. While the stock recently rallied from sub-dollar levels to trade near $5, the price action is erratic and disconnected from any earnings reality, with the company reporting significant negative free cash flow and negative returns on equity. The balance sheet shows a massive discrepancy between cash and debt relative to the tiny market cap, creating a precarious liquidity profile. There is no dividend to provide income, and the business fundamentals are deteriorating rather than improving. The statistical forecasting models offer virtually no guidance due to their extremely low reliability scores, confirming that the current price movement is likely noise rather than a sustainable trend. This is a speculative vehicle with no margin of safety. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.923219 |
| AutoARIMA | 0.955862 |
| AutoETS | 0.955864 |
| MSTL | 0.960173 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 11% |
| H-stat | 192.27 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.008 |
| Excess Kurtosis | -0.85 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 5.772 |
| Market Cap | 7,151,179 |
| Website | https://www.curanexpharma.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9600683 |
| Address1 | 2 Jericho Plaza |
| Address2 | Suite 101B |
| All Time High | 183.6 |
| All Time Low | 3.58 |
| Ask | 0.265 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 37,744 |
| Average Daily Volume3 Month | 9,983 |
| Average Volume | 9,983 |
| Average Volume10Days | 37,744 |
| Bid | 0.425 |
| Bid Size | 1 |
| Book Value | 3.376 |
| City | Jericho |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 4.56 |
| Current Ratio | 45.951 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 4.59 |
| Day Low | 4.56 |
| Debt To Equity | 5.772 |
| Display Name | Curanex Pharmaceuticals |
| Ebitda Margins | 0.0 |
| Enterprise Value | 4,489,175 |
| Eps Trailing Twelve Months | -7.38 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.5392 |
| Fifty Day Average Change | 0.020800114 |
| Fifty Day Average Change Percent | 0.0045823306 |
| Fifty Two Week Change Percent | -96.00683 |
| Fifty Two Week High | 183.6 |
| Fifty Two Week High Change | -179.04001 |
| Fifty Two Week High Change Percent | -0.9751634 |
| Fifty Two Week Low | 3.58 |
| Fifty Two Week Low Change | 0.98 |
| Fifty Two Week Low Change Percent | 0.27374303 |
| Fifty Two Week Range | 3.58 - 183.6 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,756,215,000,000 |
| Float Shares | 505,632 |
| Free Cashflow | -7,714,358 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 6 |
| Fullday Change | -0.12 |
| Fullday Change Percent | -2.5641 |
| Fullday Price | 4.62 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -7,835,752 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.61353 |
| Held Percent Institutions | 0.010650001 |
| Implied Shares Outstanding | 1,568,241 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-08-26 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,787,184,000 |
| Last Split Factor | 1:20 |
| Long Business Summary | Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York. |
| Long Name | Curanex Pharmaceuticals Inc |
| Market | us_market |
| Market Cap | 7,151,179 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1885614405 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -10,468,375 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 7,339,367 |
| Open | 4.5701 |
| Operating Cashflow | -12,079,094 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 718 673 6078 |
| Post Market Change | 0.059999943 |
| Post Market Change Percent | 1.3157883 |
| Post Market Price | 4.62 |
| Post Market Time | 1,787,959,806 |
| Previous Close | 4.68 |
| Price Hint | 4 |
| Price To Book | 1.3507109 |
| Profit Margins | 0.0 |
| Quick Ratio | 28.172 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.119999886 |
| Regular Market Change Percent | -2.5641003 |
| Regular Market Day High | 4.59 |
| Regular Market Day Low | 4.56 |
| Regular Market Day Range | 4.56 - 4.59 |
| Regular Market Open | 4.5701 |
| Regular Market Previous Close | 4.68 |
| Regular Market Price | 4.56 |
| Regular Market Time | 1,787,947,200 |
| Regular Market Volume | 4,110 |
| Return On Assets | -2.25062 |
| Return On Equity | -4.1108 |
| Sand P52 Week Change | 0.1966995 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 1,568,241 |
| Shares Percent Shares Out | 0.0008 |
| Shares Short | 1,218 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 591 |
| Short Name | Curanex Pharmaceuticals Inc |
| Short Percent Of Float | 0.002 |
| Short Ratio | 0.23 |
| Source Interval | 15 |
| State | NY |
| Symbol | CURX |
| Total Cash | 2,938,463 |
| Total Cash Per Share | 1.874 |
| Total Debt | 276,359 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -7.38 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.0381 |
| Two Hundred Day Average Change | -2.4780998 |
| Two Hundred Day Average Change Percent | -0.35209784 |
| Type Disp | Equity |
| Volume | 4,110 |
| Website | https://www.curanexpharma.com |
| Zip | 11,753 |